KARATICA IM CICA ESSENCE PACK

Manufacturer
Karatica Co., Ltd
Effective date
2019-08-16
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 23:00:05

Label at a glance#

ProductKARATICA IM CICA ESSENCE PACK
Active ingredientASIATICOSIDE, MADECASSOSIDE, MADECASSIC ACID, ASIATIC ACID
Label structure8 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Madecassoside, Asiaticoside, Madecassic Acid, Asiatic Acid

INACTIVE INGREDIENT SECTION

Water
MethylPerfluoroisobutylEther
Glycerin
ButyleneGlycol
Caprylic/CapricTriglyceride
ButyleneGlycolDicaprylate/Dicaprate
Cyclopentasiloxane
CetearylAlcohol
Coco-glucoside
Cyclohexasiloxane
GlycerylStearate
PEG-100 Stearate
PalmiticAcid
AmmoniumAcryloyldimethyltaurate/VP Copolymer
StearicAcid
SodiumLauroylGlutamate
HydrogenatedLecithin
CoptisJaponicaExtract
Propanediol
HydrolyzedPeaProtein
Prunus Amygdalus Dulcis (Sweet Almond) Shell Powder
Carbomer 940
Arginine
Betaine
ButyrospermumParkii (Shea) Butter
Ceramide NP
Melaleuca Alternifolia (Tea Tree) Leaf Water
Chlorophyllin-Copper Complex
CitricAcid
BetaineSalicylate
Gluconolactone
XanthanGum
HydrogenatedPolydecene
LauricAcid
MyristicAcid
SucroseStearate
Phytosterol
HydrogenatedPhosphatidylcholine
Lecithin
Olea Europaea (Olive) Fruit Oil
Squalane
SodiumPolyacrylate
Allantoin
1,2-Hexanediol
PentyleneGlycol
Chlorphenesin
Disodium EDTA
Fragrance
t-ButylAlcohol
Trideceth-6

OTC - PURPOSE SECTION

Removal of sebum and waste

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

keep out or reach of the children

INDICATIONS & USAGE SECTION

1.Turn on the brush and press the tube.
2.Gently apply on face avoiding eyes and lips and wait for bubbles.
3.When bubble forms, softly massage face with brush. Then wash off with warm water.
4.Make sure to turn off the brush and cleanse the brush after each use.

WARNINGS SECTION

1) Discontinue use or consult dermatologist if irritation, itching or swelling appears after applying the product.

2) Avoid applying product on the wounded, inflamed skin parts.

3) Cautions for the storage and handing

a)Keep out of children.

b)Avoid direct sun light

c)Avoid applying around eyes

DOSAGE & ADMINISTRATION SECTION

for external use only

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabel

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70514-0013-12021-01-29C16284748780-1ba0f9c33-32d0-a910-e053-dadaa90a0b859046e0e6-90b0-fa51-e053-2a95a90ab89f

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70514-0013-1KARATICA IM CICA ESSENCE PACK100 mL in 1 TUBELIQUID1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70514-0013KARATICA IM CICA ESSENCE PACK (MADECASSOSIDE, ASIATICOSIDE, MADECASSIC ACID, ASIATIC ACID) LIQUID [KARATICA CO., LTD]1Legacy NDC, 1 package rows20190819_9046e0e6-90b0-fa51-e053-2a95a90ab89f.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70514-001370514-0013-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
9046e1f3-344e-2119-e053-2a95a90a6edd9046e0e6-90b0-fa51-e053-2a95a90ab89f2019-08-16WarningsExact identifier
spl id: 9046e1f3-344e-2119-e053-2a95a90a6edd
spl set id: 9046e0e6-90b0-fa51-e053-2a95a90ab89f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.